Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Scioderm begins phase III trial of Zorblisa in patients with epidermolysis bullosa

March 20, 2015

Aldeyra Therapeutics opens enrollment in Sjogren-Larsson syndrome trial

March 19, 2015

First patient treated in Japanese phase III study of NK-kappaB decoy oligonucleotide

March 16, 2015

Stratatech reports topline results from proof-of-concept study of StrataGraft skin tissue

March 11, 2015

TWi Biotechnology receives rare disease drug designation for AC-203 in Taiwan

March 11, 2015

Pharmacokinetics of topical umeclidinium for hyperhidrosis determined

March 10, 2015

Vanda reports topline phase II results for tradipitant

March 6, 2015

FDA grants rituximab orphan drug status for pemphigus vulgaris

March 6, 2015

CHMP recommends approval of Humira for severe chronic plaque psoriasis in children

March 3, 2015

Cipher Pharmaceuticals acquires three dermatology products from Astion Pharma

March 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...